Project Grant HT94252310483
Award Date 6/1/23
Completion Date 5/31/26
Dollars Obligated $817K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45220, USA
Similar Awards
- The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
- The U.S. Defense Health Agency awarded a $860,998 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Neurophysiology of Post-Traumatic Epilepsy: Unraveling Epileptogenesis Signals Biomarkers". The grant, which runs from April 1, 2025 to March 31, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members,...
- The Department of the Army Medical Command awarded a $755,250 Project Grant to The Ohio State University Office of Sponsored Programs through the Military Medical Research and Development federal grant program. The three-year award beginning September 30, 2022 will fund research to define the genetic basis and pathologic network of post-traumatic epilepsy using Collaborative Cross mice. As part of the Military Medical Research and Development program's goals to transform military and public...
- The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- The Department of the Army Medical Command awarded a $1.66 million Project Grant to the University of Utah's Office of Sponsored Projects under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research into "Spreading Depolarizations' in the Network Dysfunction Leading to Post-Traumatic Headache." Through September 2021 to August 2024, the grantee will investigate medical solutions for post-traumatic headache on the battlefield and...
- The Defense Health Agency awarded a $488,086 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS," is intended to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The performance period...
- The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
- This Project Grant from the Defense Health Agency provides $745,381 to Virginia Commonwealth University from June 1, 2023 through May 31, 2026 to support research on "POST-TRAUMATIC EPILEPTOGENESIS: ROLE OF NEOCORTICAL-HIPPOCAMPAL INTERACTIONS" under the Military Medical Research and Development program (CFDA 12.420). VCU will conduct this research to advance the program's goals of transforming military and public healthcare through innovative biomedical research solutions. Subawards...
- The Department of the Army Medical Command awarded a $413,400 Project Grant to Children's Home Healthcare of Cincinnati, OH through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2023 exploring the role of endoplasmic reticulum stress and systemic inflammation in blunt traumatic brain injury-induced optic nerve damage. The Military Medical Research and Development program supports basic, applied, and...